This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cao XX, Xu JD, Liu XL, Xu JW, Cheng YY, Wang WJ et al. (2010b). RACK1: a superior independent predictor for poor clinical outcome in breast cancer. Int J Cancer 127: 1172–1179.
Cao XX, Xu JD, Xu JW, Liu XL, Cheng YY, Li QQ et al. (2010a). RACK1 promotes breast carcinoma migration/metastasis via activation of the RhoA/Rho kinase pathway. Breast Cancer Res Treat (e-pub ahead of print; doi:10.1007/s10549-010-0955-3).
Cao XX, Xu JD, Xu JW, Liu XL, Cheng YY, Wang WJ et al. (2009). RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo. Breast Cancer Res Treat (e-pub ahead of print; doi:10.1007/s10549-1009-0657-x).
Wang Z, Jiang L, Huang C, Li Z, Chen L, Gou L et al. (2008). Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol Cell Proteomics 7: 1639–1650.
Wang Z, Zhang B, Jiang L, Zeng X, Chen Y, Feng X et al. (2009). RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67. Eur J Cancer 45: 490–496.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cao, XX., Liu, XP. Response to ‘Evidence for a pro-apoptotic function of RACK1 in human breast cancer’. Oncogene 29, 5652 (2010). https://doi.org/10.1038/onc.2010.293
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.293